A new chemical tool to analyze plant hormone pathways is established by Prof. Dr. Markus Kaiser, Centre for Medical Biotechnology, University of Duisburg-Essen (UDE), and Dr. Erich Kombrink, Max Planck Institute for Plant Breeding Research, Cologne. In the latest issue of „Nature Chemical Biology“, the researchers disclose a small molecule inhibitor, which interferes with the activity of the plant hormone jasmonic acid. The approach resembles concepts, which are well established in medical therapy and opens new opportunities for plant research. (Doi:10.1038/nchembio.1591).
Currently, research into plant hormone signalling relies primarily on molecular genetics. Genes of interest are modified or extinguished to then study resultant changes in the plant’s phenotype. This strategy is powerful but has its limitations, as is highlighted by the plant hormone jasmonic acid.
Although jasmonic acid controls a diversity of biological functions, as flower formation, root growth, protection against insect attack and infections, wound healing, plant aging and others, only one signal transduction pathway has been elucidated so far.
This single pathway however is not sufficient to explain the broad spectrum of hormone actions. Other, so far unknown, signaling pathways and mechanisms must exist. To get a better understanding of jasmonic acid’s signaling mechanisms, alternative experimental approaches are therefore required. The teams from Essen and Cologne took up this challenge and used a procedure, which is well established in medical research but still rarely used in plant science:
They searched for a chemical drug that can be used to block a specific signalling pathway. In medicine, such compounds find applications as drugs to treat diseases. In plant science, however, such inhibitors may represent important chemical tools to advance the study of plant signalling pathways.
In the search of candidate inhibitors of jasmonic acid signalling, the scientists performed studies in intact plants. They started with a screening in the ‘model plant’ Arabidopsis thaliana. From 1.728 tested compounds, 16 molecules were identified that impaired jasmonic acid signalling. These were then studied in more detail and finally, only one compound was confirmed as a suitable specific inhibitor.
The compound was called Jarin-1. “Structurally, the compound is a plant alkaloid whose amino groups may carry different side chains” the researchers comment. “The activity of the compound depends on a specific side chain. Modifications deactivate the inhibitor. As a final proof of the active chemical structure, we synthesized it from scratch.’
As a next step the scientists looked for the molecular target of the new inhibitor. The already known signal transduction pathway of jasmonic acid starts with an enzyme called JAR1 that links the plant hormone jasmonic acid to the amino acid isoleucine. The resulting chemical product then modulates the transcription of various genes that together form the particular biological activity of jasmonic acid.
Kombrink and Kaiser were able to show that this enzyme JAR1 is the target of the inhibitor Jarin-1. Inhibition of JAR1 causes depletion of the required jasmonic acid-isoleucine conjugate, thus impairing gene transcription. They furthermore found that the molecule Jarin-1 is not only active in Arabidopsis but also in Candamine hirsuta, lamb’s cress. Therefore, the inhibitor seems to be broadly applicable and thus may be used in future applications to advance the understanding of jasmonic acid signalling.
What is particular about this new approach and caused the renowned journal “Nature Chemical Biology” to publish the work? Small molecules are promising new tools for plant research. The scientists demonstrate exemplarily how to screen for a specific small molecule inhibitor, how to characterize it and how to identify its target protein and they point out possible applications. The scope of the study turns the publication into something highly special.
Dr. Erich Kombrink
Max-Planck-Institut for Plant Breeding Research
Telefon: +49 221 5062 320
Prof. Dr. Markus Kaiser
Center for Medical Biotechnology
Beate Kostka | idw - Informationsdienst Wissenschaft
A novel socio-ecological approach helps identifying suitable wolf habitats
17.02.2017 | Universität Zürich
New, ultra-flexible probes form reliable, scar-free integration with the brain
16.02.2017 | University of Texas at Austin
In the field of nanoscience, an international team of physicists with participants from Konstanz has achieved a breakthrough in understanding heat transport
Cells need to repair damaged DNA in our genes to prevent the development of cancer and other diseases. Our cells therefore activate and send “repair-proteins”...
The Fraunhofer IWS Dresden and Technische Universität Dresden inaugurated their jointly operated Center for Additive Manufacturing Dresden (AMCD) with a festive ceremony on February 7, 2017. Scientists from various disciplines perform research on materials, additive manufacturing processes and innovative technologies, which build up components in a layer by layer process. This technology opens up new horizons for component design and combinations of functions. For example during fabrication, electrical conductors and sensors are already able to be additively manufactured into components. They provide information about stress conditions of a product during operation.
The 3D-printing technology, or additive manufacturing as it is often called, has long made the step out of scientific research laboratories into industrial...
Nature does amazing things with limited design materials. Grass, for example, can support its own weight, resist strong wind loads, and recover after being...
Nanometer-scale magnetic perforated grids could create new possibilities for computing. Together with international colleagues, scientists from the Helmholtz Zentrum Dresden-Rossendorf (HZDR) have shown how a cobalt grid can be reliably programmed at room temperature. In addition they discovered that for every hole ("antidot") three magnetic states can be configured. The results have been published in the journal "Scientific Reports".
Physicist Dr. Rantej Bali from the HZDR, together with scientists from Singapore and Australia, designed a special grid structure in a thin layer of cobalt in...
13.02.2017 | Event News
10.02.2017 | Event News
09.02.2017 | Event News
20.02.2017 | Power and Electrical Engineering
17.02.2017 | Medical Engineering
17.02.2017 | Medical Engineering